Delta 9 Cannabis Just Become Profitable: Pot Stocks to Watch

Delta 9 Cannabis

Last week, Aurora was the biggest winner in the cannabis space. It gained nearly 70% in a single session after posting strong financial results for Q3 2020. Today, we’ll be looking at this weeks big winner: Delta 9 Cannabis Inc. (TSX:DN) (OTCQX:VRNDF), which also posted its most recent fiscal earnings.

Rich previously profiled this promising pot stock earlier this year. Now, Co-Founder and CEO John Arbuthnot has returned to discuss how his company has been progressing.

To refresh: Delta 9 Cannabis is a vertically integrated company focused on bringing the highest quality cannabis products to market. The company’s wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis. It operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand.

Enter Your E-mail Address To Subscribe

* indicates required

Delta 9 Reports Record Quarterly Results

According to the company’s Q1 2020 financial earnings, operating revenues came to $11.75 million for the three-month period ending March 31. This is up 109% from $5.63 million for the same quarter in 2019. In addition, adjusted EBITDA was $1.65 million, an improvement from an adjusted EBITDA loss of $1.98 million in Q1 2019.

Thus, with an earnings per share of $0.02, Delta 9 Cannabis has joined the exclusive ranks of “profitable cannabis companies.” This is a major win for the company, especially given the ongoing COVID-19 crisis. Arbuthnot notes that the company remained fully operational through the quarter, and continues to increase its sales to this day.

Also of note from Q1, Delta 9 received approval from Health Canada for its new purpose-built cannabis processing center. This will allow it to fully automate bottling, packaging, capping, and labeling of its consumer-packaged dried cannabis products.

Delta 9 Cannabis Receives Positive Recommendation

The company’s strong results led Canaccord Genuity to raise its price target from $0.60 to $0.75. The firm also ranked DN a Speculative Buy. Discussing the company’s future, analyst Kimberly Hedlin opined:

“We believe a pipeline of Grow Pod projects will continue to boost revenues over the next couple of quarters while retail store growth should provide a conduit for wholesale distribution over the coming 24 months.”

What do you think, is Delta 9 now one of the must-follow pot stocks? Keep watching RichTV for more updates about this and other exciting companies.

Featured image: Unsplash © Martijn Baudoin

Please See Disclaimer

If You Liked This Article Click To Share

Risks and Disclosure:

Information provided in this correspondence is intended solely for informational purposes and is obtained from sources believed to be reliable. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on this website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions made or suggested and the actual results.

All statements and opinions expressed are the opinions of the author and not of or its officers. The author is wholly responsible for the validity of all statements. was not involved in any aspect of the article preparation. The author was not paid by Bitrex Inc for this article. The author did not pay to publish or syndicate this article.

This article does not constitute as investment advice. Each reader is encouraged to consult with his or her individual financial advisor; any and all actions taken by a reader as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to's terms of use and full legal disclaimer. This article is in no way a solicitation for investment. does not render general or specific investment advice. Any information on should not be considered a recommendation to buy or sell any security. does not endorse or recommend the business, products, services or securities of any company mentioned on

Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks, and options may fluctuate, and, as a result, clients may lose more than their original investment and possibly their entire investment. Any content on this website should not be relied upon as advice or construed as providing recommendations of any kind. It is your responsibility to confirm and decide which trades to make. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Please see our full disclaimer here for additional details before making any investment decisions.